HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by OneDigital Investment Advisors LLC

OneDigital Investment Advisors LLC cut its stake in HCA Healthcare, Inc. (NYSE:HCA) by 3.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,225 shares of the company’s stock after selling 42 shares during the period. OneDigital Investment Advisors LLC’s holdings in HCA Healthcare were worth $498,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of HCA. Acadian Asset Management LLC lifted its position in HCA Healthcare by 115.5% in the 1st quarter. Acadian Asset Management LLC now owns 3,372 shares of the company’s stock valued at $1,123,000 after purchasing an additional 1,807 shares during the last quarter. Bessemer Group Inc. raised its stake in shares of HCA Healthcare by 51.2% during the first quarter. Bessemer Group Inc. now owns 7,629 shares of the company’s stock valued at $2,543,000 after purchasing an additional 2,584 shares in the last quarter. CreativeOne Wealth LLC acquired a new position in shares of HCA Healthcare during the first quarter valued at approximately $231,000. Advisors Asset Management Inc. increased its position in shares of HCA Healthcare by 117.5% during the 1st quarter. Advisors Asset Management Inc. now owns 2,543 shares of the company’s stock valued at $848,000 after purchasing an additional 1,374 shares during the period. Finally, Toronto Dominion Bank lifted its holdings in shares of HCA Healthcare by 1.4% in the first quarter. Toronto Dominion Bank now owns 114,189 shares of the company’s stock valued at $38,085,000 after buying an additional 1,593 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the stock. Royal Bank of Canada lifted their price target on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research report on Friday, August 23rd. Wolfe Research upgraded shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. TD Cowen decreased their target price on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research report on Monday, October 28th. Leerink Partners lifted their target price on HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. Finally, StockNews.com cut shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Five research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $385.00.

HCA Healthcare Stock Performance

HCA stock opened at $333.00 on Thursday. The firm has a market cap of $84.35 billion, a PE ratio of 14.95, a P/E/G ratio of 1.32 and a beta of 1.68. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The business has a 50 day moving average of $381.99 and a 200-day moving average of $358.12. HCA Healthcare, Inc. has a 12-month low of $245.84 and a 12-month high of $417.14.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be given a $0.66 dividend. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.79%. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.85%.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the firm’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This trade represents a 21.97 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares in the company, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 15,155 shares of company stock worth $5,608,990 in the last three months. 1.70% of the stock is currently owned by corporate insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.